APA (7th ed.) Citation

Zhao, J., Liu, M., Zhu, C., Li, Z., Liu, Z., Abulizi, D., . . . Hou, X. (2025). Cancer-associated fibroblasts and metabolic reprogramming predict pathologic response to neoadjuvant PD-1 blockade in resected non-small cell lung cancer. Cellular Oncology (2211-3428), 48(4), 1105. https://doi.org/10.1007/s13402-025-01067-4

Chicago Style (17th ed.) Citation

Zhao, Jiaqi, et al. "Cancer-associated Fibroblasts and Metabolic Reprogramming Predict Pathologic Response to Neoadjuvant PD-1 Blockade in Resected Non-small Cell Lung Cancer." Cellular Oncology (2211-3428) 48, no. 4 (2025): 1105. https://doi.org/10.1007/s13402-025-01067-4.

MLA (9th ed.) Citation

Zhao, Jiaqi, et al. "Cancer-associated Fibroblasts and Metabolic Reprogramming Predict Pathologic Response to Neoadjuvant PD-1 Blockade in Resected Non-small Cell Lung Cancer." Cellular Oncology (2211-3428), vol. 48, no. 4, 2025, p. 1105, https://doi.org/10.1007/s13402-025-01067-4.